These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 19738289)

  • 1. [Controversies in hypertrophic cardiomyopathy].
    Hardarson T
    Laeknabladid; 2009 Sep; 95(9):555. PubMed ID: 19738289
    [No Abstract]   [Full Text] [Related]  

  • 2. Dealing with a special group: hypertrophic cardiomyopathy. Pharmacological treatment.
    Brito D
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V47-9. PubMed ID: 10582458
    [No Abstract]   [Full Text] [Related]  

  • 3. Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
    Horowitz JD; Chirkov YY
    Circulation; 2010 Oct; 122(16):1547-9. PubMed ID: 20921436
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of hypertrophic cardiomyopathy.
    Hopf R; Kaltenbach M
    Annu Rev Med; 1990; 41():75-83. PubMed ID: 2184751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midodrine hydrochloride and unexpected improvement in hypertrophic cardiomyopathy symptoms.
    Lafitte S; Peyrou J; Reynaud A; Dijos M; Cornolle C; Roudaut R; Touche C; Ritter P; Réant P
    Arch Cardiovasc Dis; 2016 Mar; 109(3):223-5. PubMed ID: 26898633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy with restrictive pathophysiology: is there a role for cardiopulmonary exercise testing?].
    Correale M; Passero T; Totaro A; Di Biase M
    G Ital Cardiol (Rome); 2012 Dec; 13(12):861; author's reply p.861. PubMed ID: 23196690
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of symptoms in hypertrophic cardiomyopathy.
    Fifer MA; Vlahakes GJ
    Circulation; 2008 Jan; 117(3):429-39. PubMed ID: 18212300
    [No Abstract]   [Full Text] [Related]  

  • 8. September 2016 at a glance: pregnancy, hypertrophic cardiomyopathy, epidemiology, medical treatment.
    Metra M
    Eur J Heart Fail; 2016 Sep; 18(9):1091-2. PubMed ID: 27594173
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy.
    Kaltenbach M; Hopf R; Kober G
    Circulation; 1997 Sep; 96(6):2080. PubMed ID: 9323103
    [No Abstract]   [Full Text] [Related]  

  • 10. Nifedipine in hypertrophic cardiomyopathy.
    Pouleur H; Rousseau MF
    Circulation; 1982 Aug; 66(2):478-9. PubMed ID: 7201360
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and Controversies in Hypertrophic Cardiomyopathy: Clinical, Genomic and Basic Science Perspectives.
    Pasipoularides A
    Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):132-138. PubMed ID: 28802532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of Presentations and Discussions of Hypertrophic Cardiomyopathy at the 2018 Boston International Summit VI Including Consensus, Controversies, and Unmet Needs.
    Maron BJ; Maron MS
    Am J Cardiol; 2018 Oct; 122(7):1281-1286. PubMed ID: 30173818
    [No Abstract]   [Full Text] [Related]  

  • 13. What causes outflow tract obstruction in hypertrophic cardiomyopathy?
    Ommen SR; Nishimura RA
    Heart; 2009 Nov; 95(21):1725-6. PubMed ID: 19628468
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy centers.
    Maron BJ
    Am J Cardiol; 2009 Oct; 104(8):1158-9. PubMed ID: 19801041
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk assessment with cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Gosling OE; Bellenger N; Spurrell P
    Heart; 2009 Nov; 95(22):1843. PubMed ID: 19875370
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy: ask athletes these 9 questions.
    deWeber K; Beutler A
    J Fam Pract; 2009 Nov; 58(11):576-84. PubMed ID: 19891935
    [No Abstract]   [Full Text] [Related]  

  • 19. Obstructive sleep apnea a respiratory syndrome with protean cardiovascular manifestations.
    Wilcox I; Semsarian C
    J Am Coll Cardiol; 2009 Nov; 54(19):1810-2. PubMed ID: 19874996
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
    Eleid MF; Konecny T; Orban M; Sengupta PP; Somers VK; Parish JM; Mookadam F; Brady PA; Sullivan BL; Khandheria BK; Ommen SR; Tajik AJ
    J Am Coll Cardiol; 2009 Nov; 54(19):1805-9. PubMed ID: 19874995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.